| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |